Millions for Proteomics Research in the Peer Reviewed Medical Research Program
Millions for Proteomics Research in the Peer Reviewed Medical Research Program
How SomaLogic technologies can give your research programs an edge.
Topics Covered
- Overview of the Peer Reviewed Medical Research Program (PRMRP) and Congressionally Directed Medical Research Programs (CDMRP)
- Overview of SomaLogic technologies that can give your research programs an edge
- How the PRMRP application process is unique to other U.S. government grant programs
- “Best Practices” for a successful PRMRP application
Tammy Hicks
Tammy Hicks is the Associate Director for the Southeast U.S. for SomaLoigic and has over 24 years of experience leading, mentoring, and selling in the Life Sciences market. She has supported many sectors, including academic research centers, pharmaceutical companies, and diagnostic testing providers. Tammy’s understanding of research and how to translate research findings into practical, actionable information for patients and physicians alike has allowed her to assist with many projects that improve health outcomes and deepen our understanding of human biology.
Elizabeth Barrows
Elizabeth “Liz” Barrows is a federal funding consultant whose clients have secured in excess of $100M over the course of her 10+-year career. Liz’s in-depth knowledge of the Department of Defense (DoD) funding opportunities and needs has a basis in experience at the DoD, where she managed pharmaceutical research and development projects in, and reviewed proposals for, blood products, resuscitation fluids and analgesic drugs for the U.S. Army from 2004-2009. She has also worked with NASA and private industry on the development of biomedical sensors, robotics, in vitro diagnostics, and blood products. She holds a master’s degree in biomedical engineering.
Millions for Proteomics Research in the Peer Reviewed Medical Research Program
A presentation by Tammy Hicks and Elizabeth Barrows
More webinars
WebinarB Cell Repertoire in Determining Responses to Checkpoint Blockade in NSCLC
In this webinar, Gary Middleton, MD, PhD, and Akshay Patel, PhD, from the University of Birmingham explore the role of the B cell repertoire and autoantibodies in shaping responses to checkpoint blockade immunotherapy in non-small-cell lung cancer (NSCLC). They demonstrate how autoantibody profiling using the i-Ome™ Discovery protein microarray revealed biomarkers predictive of treatment efficacy and immune-related adverse events (irAEs), providing insights into biomarker development and personalized immunotherapy strategies.
WebinarSerum Autoantibodies Differentiate Rheumatoid Arthritis Subgroups
Patients with rheumatoid arthritis (RA) can be categorized as either anti-citrullinated protein antibody-positive (ACPA+) or negative (ACPA-). In this webinar, Dr. Sung will present his research exploring a broad range of serological autoantibodies to uncover immunological differences between these RA subgroups using data from ACPA+ RA patients, ACPA- RA patients, and matched healthy controls.
WebinarData Summit 2025
Take your research further with expert insights from the SomaScan™ Data Summit. Explore the latest platform updates, advanced data analysis tools, and innovative applications for SOMAmer™ reagents. From optimizing sample quality to customizing panels beyond 7K and 11K, this event is packed with knowledge to help you get the most from your data.